Benefits of upstream seed train intensification & high-density cell banking

Watch the video or view the poster to learn more about: Benchmarking cryopreservation cell recovery  Process economics of intensified high-density cell banking  Intensified frozen cell recovery  How high-density cell banking enables greater process automation

Patrick Shu Miao has spent many years working with vaccine manufacturers and global device suppliers in the biopharmaceutical industry and has experience in downstream processes, quality control, and online technology. He worked for PALL and Mettler Toledo before joining Entegris and the sterile filtration field, with a focus on process analytical technologies (PAT) for upstream and downstream biopharma control.

Please enter your email to access content Read now